Recombinant BRD4 anticorps (AA 1312-1362)
Aperçu rapide pour Recombinant BRD4 anticorps (AA 1312-1362) (ABIN7454041)
Antigène
Voir toutes BRD4 AnticorpsType d'anticorp
Reactivité
Hôte
Clonalité
Conjugué
Application
Clone
-
-
Épitope
- AA 1312-1362
-
Fonction
- Rabbit anti-BRD4 Recombinant Monoclonal Antibody [BL-151-6F11]
-
Immunogène
- between AA 1312 and 1362
-
Isotype
- IgG
-
-
-
-
Indications d'application
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Concentration
- 1000 μg/mL
-
Buffer
- Borate Buffered Saline (BBS) pH 8.2 with 0.09 % Sodium Azide, BSA-Free
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- 4 °C
-
Date de péremption
- 12 months
-
-
- BRD4 (Bromodomain Containing 4 (BRD4))
-
Autre désignation
- BRD4
-
Sujet
- Background: Bromodomain-containing protein 4 (BRD4) contains 2 bromo-domains. Bromo-domains are found in chromatin-associating proteins and can interact specifically with acetylated lysine. BRD4 is described as a chromatin adaptor and has been shown to bind acetylated chromatin. It was originally identified as MCAP (mitotic chromosome associated protein) due to its association with mitotic chromosomes. BRD4 also associates with several transcription complexes such as the Mediator complexes and P-TEFb complexes and is considered to function as a transcriptional co-factor.
-
ID gène
- 23476
-
NCBI Accession
- NP_490597
-
UniProt
- O60885
-
Pathways
- Chromatin Binding, SARS-CoV-2 Protein Interactome
Antigène
-